SSC

Spruce Street Capital Portfolio holdings

AUM $303M
This Fund
S&P 500
This Quarter Est. Return
1 Year Est. Return
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$303M
AUM Growth
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
27
New
Increased
Reduced
Closed

Top Buys

1 +$37.5M
2 +$21.3M
3 +$17.9M
4
LBRX
LB Pharmaceuticals
LBRX
+$17.6M
5
KNSA icon
Kiniksa Pharmaceuticals
KNSA
+$17.4M

Top Sells

No sells this quarter

Sector Composition

1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CDTX
1
DELISTED
Cidara Therapeutics
CDTX
$51.3M 16.95%
+232,269
RLAY icon
2
Relay Therapeutics
RLAY
$1.62B
$25.2M 8.34%
+2,984,125
LBRX
3
LB Pharmaceuticals
LBRX
$631M
$22.4M 7.4%
+1,005,593
RLMD icon
4
Relmada Therapeutics
RLMD
$321M
$19.7M 6.52%
+4,086,181
PCVX icon
5
Vaxcyte
PCVX
$8.79B
$18.5M 6.1%
+400,360
KNSA icon
6
Kiniksa Pharmaceuticals
KNSA
$3.35B
$17.9M 5.93%
+434,982
EYPT icon
7
EyePoint Inc
EYPT
$1.42B
$17.9M 5.93%
+981,543
SVRA icon
8
Savara
SVRA
$1.17B
$14.5M 4.8%
+2,411,093
ERAS icon
9
Erasca
ERAS
$4.22B
$14.5M 4.78%
+3,889,632
DNTH icon
10
Dianthus Therapeutics
DNTH
$2.32B
$12.3M 4.05%
+297,437
SRZN icon
11
Surrozen
SRZN
$231M
$9.76M 3.23%
+432,040
OCUL icon
12
Ocular Therapeutix
OCUL
$1.93B
$9.52M 3.14%
+783,999
SABS icon
13
SAB Biotherapeutics
SABS
$179M
$8.22M 2.72%
+2,198,502
IKT icon
14
Inhibikase Therapeutics
IKT
$238M
$7.34M 2.43%
+3,581,603
ELVN icon
15
Enliven Therapeutics
ELVN
$1.65B
$6.87M 2.27%
+446,084
NERV icon
16
Minerva Neurosciences
NERV
$275M
$6.66M 2.2%
+1,655,500
ABVX
17
Abivax
ABVX
$10.1B
$6.62M 2.19%
+49,119
HELP
18
Cybin Inc
HELP
$348M
$6.3M 2.08%
+770,000
KALV icon
19
KalVista Pharmaceuticals
KALV
$798M
$6.27M 2.07%
+387,968
ENTA icon
20
Enanta Pharmaceuticals
ENTA
$421M
$6.15M 2.03%
+389,687
ANRO icon
21
Alto Neuroscience
ANRO
$578M
$3.97M 1.31%
+222,844
LONA
22
LeonaBio Inc
LONA
$56.3M
$2.98M 0.98%
+393,701
CNTA
23
Centessa Pharmaceuticals
CNTA
$3.89B
$1.95M 0.64%
+77,997
ALEC icon
24
Alector
ALEC
$232M
$1.74M 0.58%
+1,117,986
LXEO icon
25
Lexeo Therapeutics
LXEO
$483M
$1.74M 0.57%
+175,000